Targeted inhibition of tumour cell growth by a bispecific single-chain toxin containing an antibody domain and TGF alpha.

por Schmidt, M., Wels, W.
Publicado 1996

Immunotoxins: experimental design

por Dall, P, Wels, W
Publicado 2001

Bispecific costimulatory molecules for activation of tumor-killing lymphocytes

por Weth, R, Biburger, M, Wels, W
Publicado 2004

Construction and functional characterization of scFv(14E1)-ETA - a novel, highly potent antibody-toxin specific for the EGF receptor.

por Schmidt, M., Vakalopoulou, E., Schneider, D. W., Wels, W.
Publicado 1997

Monoclonal antibodies directed to the erbB-2 receptor inhibit in vivo tumour cell growth.

por Harwerth, I. M., Wels, W., Schlegel, J., Müller, M., Hynes, N. E.
Publicado 1993

Induction of effective and antigen-specific antitumour immunity by a liposomal ErbB2/HER2 peptide-based vaccination construct

por Roth, A, Rohrbach, F, Weth, R, Frisch, B, Schuber, F, Wels, W S
Publicado 2005

Potent antitumoral activity of TRAIL through generation of tumor-targeted single-chain fusion proteins

por Schneider, B, Münkel, S, Krippner-Heidenreich, A, Grunwald, I, Wels, W S, Wajant, H, Pfizenmaier, K, Gerspach, J
Publicado 2010

AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma

por Strecker, M.I., Wlotzka, K., Strassheimer, F., Roller, B., Ludmirski, G., König, S., Röder, J., Opitz, C., Alekseeva, T., Reul, J., Sevenich, L., Tonn, T., Wels, W.S., Steinbach, J.P., Buchholz, C.J., Burger, M.C.
Publicado 2022